Dario Ballinari

3.1k total citations
54 papers, 1.1k citations indexed

About

Dario Ballinari is a scholar working on Molecular Biology, Oncology and Immunology. According to data from OpenAlex, Dario Ballinari has authored 54 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 34 papers in Molecular Biology, 20 papers in Oncology and 14 papers in Immunology. Recurrent topics in Dario Ballinari's work include Cancer therapeutics and mechanisms (11 papers), Immunotherapy and Immune Responses (10 papers) and Monoclonal and Polyclonal Antibodies Research (9 papers). Dario Ballinari is often cited by papers focused on Cancer therapeutics and mechanisms (11 papers), Immunotherapy and Immune Responses (10 papers) and Monoclonal and Polyclonal Antibodies Research (9 papers). Dario Ballinari collaborates with scholars based in Italy, United States and New Zealand. Dario Ballinari's co-authors include Giorgio Parmiani, Enrico Pesenti, Federico Spreafico, Nadia Amboldi, Massimo Broggini, Mario P. Colombo, Cristina Geroni, Maurizio D’Incalci, Eugenio Erba and Maria Grandi and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Clinical Oncology and The Journal of Immunology.

In The Last Decade

Dario Ballinari

53 papers receiving 1.0k citations

Peers

Countries citing papers authored by Dario Ballinari

Since Specialization

Citations

This map shows the geographic impact of Dario Ballinari's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dario Ballinari with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dario Ballinari more than expected).

Fields of papers citing papers by Dario Ballinari

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Dario Ballinari. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dario Ballinari. The network helps show where Dario Ballinari may publish in the future.

Co-authorship network of co-authors of Dario Ballinari

This figure shows the co-authorship network connecting the top 25 collaborators of Dario Ballinari. A scholar is included among the top collaborators of Dario Ballinari based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Dario Ballinari. Dario Ballinari is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Afatinib Is a New Therapeutic Approach in Chordoma with a Unique Ability to Target EGFR and Brachyury 2017 ·Molecular Cancer Therapeutics ·Paola Magnaghi, Barbara Salom, Liviana Cozzi, Nadia Amboldi, Dario Ballinari, Elena Tamborini, Fabio Gasparri, Alessia Montagnoli, Laura Raddrizzani, Alessio Somaschini, Roberta Bosotti, Christian Orrenius, Fabio Bozzi, Silvana Pilotti, Arturo Galvani, Josh Sommer, Silvia Stacchiotti, Antonella Isacchi	59
2	Establishment and genomic characterization of the new chordoma cell line Chor-IN-1 2017 ·Scientific Reports ·Roberta Bosotti, Paola Magnaghi, Sebastiano Di Bella, Liviana Cozzi, (unknown), Fabio Bozzi, (unknown), (unknown), Dario Ballinari, Nadia Amboldi, Rosita Lupi, Alessio Somaschini, Laura Raddrizzani, Barbara Salom, Arturo Galvani, Silvia Stacchiotti, Elena Tamborini, Antonella Isacchi	12
3	Mcl-1 antagonism is a potential therapeutic strategy in a subset of solid cancers 2014 ·Experimental Cell Research ·(unknown), Patrizia Banfi, Fabio Gasparri, R. M. Borzilleri, Percy Carter, Lyndon A. M. Cornelius, Marco M. Gottardis, (unknown), Claudio Mapelli, Joseph G. Naglich, Andrew J. Tebben, Gregory D. Vite, Wilma Pastori, Clara Albanese, Emiliana Corti, Dario Ballinari, Arturo Galvani	27
4	Cell Line Identity Finding by Fingerprinting, an Optimized Resource for Short Tandem Repeat Profile Authentication 2013 ·Genetic Testing and Molecular Biomarkers ·Alessio Somaschini, Nadia Amboldi, Angelo Nuzzo, Emanuela Scacheri, (unknown), Dario Ballinari, Jolanta Małyszko, Laura Raddrizzani, (unknown), Fabio Gasparri, Arturo Galvani, Antonella Isacchi, Roberta Bosotti	9
5	9‐Fluorenone‐2‐Carboxylic Acid as a Scaffold for Tubulin Interacting Compounds 2013 ·ChemPlusChem ·Francesco Calogero, (unknown), Gaetano Speciale, Michael S. Christodoulou, Daniele Cartelli, Dario Ballinari, Francesco Sola, Clara Albanese, Antonella Ciavolella, Daniele Passarella, Graziella Cappelletti, Stefano Pieraccini, Maurizio Sironi	8
6	5-(2-Amino-pyrimidin-4-yl)-1H-pyrrole and 2-(2-amino-pyrimidin-4-yl)-1,5,6,7-tetrahydro-pyrrolo[3,2-c]pyridin-4-one derivatives as new classes of selective and orally available Polo-like kinase 1 inhibitors 2011 ·Bioorganic & Medicinal Chemistry Letters ·Michele Caruso, Barbara Valsasina, Dario Ballinari, J. A. Bertrand, Maria Gabriella Brasca, Marina Caldarelli, Paolo Cappella, Francesco Fiorentini, Laura Gianellini, Alessandra Scolaro, Italo Beria	17
7	Dual Targeting of CDK and Tropomyosin Receptor Kinase Families by the Oral Inhibitor PHA-848125, an Agent with Broad-Spectrum Antitumor Efficacy 2010 ·Molecular Cancer Therapeutics ·Clara Albanese, Rachele Alzani, Nadia Amboldi, Nilla Avanzi, Dario Ballinari, Maria Gabriella Brasca, Claudio Festuccia, Francesco Fiorentini, Giuseppe Locatelli, Wilma Pastori, Veronica Patton, Fulvia Roletto, Francesco Colotta, Arturo Galvani, Antonella Isacchi, Jürgen Moll, Enrico Pesenti, Ciro Mercurio, Marina Ciomei	51
8	Doxazosin-Related α ₁ -Adrenoceptor Antagonists With Prostate Antitumor Activity 2009 ·Journal of Medicinal Chemistry ·Dario Giardinà, Daniele Martarelli, Gianni Sagratini, Piero Angeli, Dario Ballinari, (unknown), Carlo Melchiorre, Elena Poggesi, Pierluigi Pompei	33
9	Design, Synthesis, and Biological Evaluation of Levoglucosenone‐Derived Ras Activation Inhibitors 2009 ·ChemMedChem ·(unknown), (unknown), Dario Ballinari, Sonia Colombo, Alessandro Bitto, Enzo Martegani, Cristina Airoldi, (unknown), Matthias Stein, (unknown), C Battistini, Francesco Peri	33
10	Antitumor Efficacy of Edotecarin as a Single Agent and in Combination with Chemotherapy Agents in a Xenograft Model 2006 ·Clinical Cancer Research ·Marina Ciomei, Valter Croci, Antonella Ciavolella, Dario Ballinari, Enrico Pesenti	9
11	Nemorubicin: A doxorubicin-like structure with a novel mechanism of action different from anthracyclines 2006 ·Cancer Research ·Cristina Geroni, Maria Antonietta Sabatino, Dario Ballinari, Marina Ciomei, Aurelio Marsiglio, Luigi Quintieri, Maura Floreani, Massimo Broggini	2
12	In vitro cell growth pharmacodynamic studies: a new nonparametric approach to determining the relative importance of drug concentration and treatment time 2003 ·Cancer Chemotherapy and Pharmacology ·Massimiliano Germani, Paolo Magni, Giuseppe De Nicolao, Italo Poggesi, Aurelio Marsiglio, Dario Ballinari, Maurizio Rocchetti	8
13	4′-Iodo-4′-Deoxydoxorubicin Disrupts the Fibrillar Structure of Transthyretin Amyloid 2000 ·American Journal Of Pathology ·Joana Almeida Palha, Dario Ballinari, Nadia Amboldi, Isabel Cardoso, Rui Fernandes, Vittorio Bellotti, Giampaolo Merlini, Maria João Saraiva	52
14	Reversal of Multidrug Resistance by New Dihydropyridines with Low Calcium Antagonist Activity 1994 ·Acta Oncologica ·Laura Capolongo, Nadia Amboldi, Dario Ballinari, Paolo Cozzi, (unknown), Marina Ripamonti, (unknown), Maria Grandi	3
15	Biological profile of FCE 24517, a novel benzoyl mustard analogue of distamycin A 1991 ·British Journal of Cancer ·Gabriella Pezzoni, Maria Grandi, (unknown), Laura Capolongo, Dario Ballinari, (unknown), B Barbieri, Ambra Pastori, Enrico Pesenti, Nicola Mongelli	60
16	Modulation of multidrug resistance by verapamil or mdr1 anti‐sense oligodeoxynucleotide does not change the high susceptibility to lymphokine‐activated killers in mdr‐resistant human carcinoma (LoVo) line 1990 ·International Journal of Cancer ·Licia Rivoltini, Mario P. Colombo, Rosanna Supino, Dario Ballinari, Takashi Tsuruo, Giorgio Parmiani	53
17	Novel anthracycline analogs 1990 ·Cancer Treatment Reviews ·Maria Grandi, Gabriella Pezzoni, Dario Ballinari, Laura Capolongo, (unknown), Alberto Bargiotti, (unknown), Federico Spreafico	37
18	Ultrastructural cytoskeleton alterations and modification of actin expression in the NIH/3T3 cell line after transformation with Ha‐ras‐Activated oncogene 1990 ·Cell Motility and the Cytoskeleton ·Luciano Lombardi, Dario Ballinari, Italia Bongarzone, (unknown), Piera Mondellini, (unknown), S. Modina	25
19	Pharmacology and Clinical Toxicity of 4'-Iodo-4'-deoxydoxorubicin: An Example of Successful Application of Pharmacokinetics to Dose Escalation in Phase I Trials 1990 ·JNCI Journal of the National Cancer Institute ·Luca Gianni, Lucia Viganò, Antonella Surbone, Dario Ballinari, Paolo G. Casali, Corrado Tarella, Jerry M. Collins, Gianni Bonadonna	54
20	Monoclonal Antibodies Against NIH 3T3 Cells Transformed by Human Thyroid Carcinoma DNA 1988 ·Hybridoma ·Rachele Alzani, Marco A. Pierotti, Sylvie Ménard, Silvana Canevari, (unknown), Dario Ballinari, Catia Traversari, Gabriella Della Torre, Paolo Radice, Silvana Pilotti, Alfredo Fusco, Michèle Grieco, Giuseppe Della Porta, Maria I. Colnaghi	1

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact